Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 307 clinical trials
Amplatzer Amulet LAAO vs. NOAC

The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy. The clinical investigation is a prospective, randomized, multicenter active control …

noac
electrocardiogram
vitamin
left atrial appendage occlusion
embolism
  • 0 views
  • 16 Feb, 2024
  • 1 location
Ablation of Fibrotic Areas in Patients With Persistent Atrial Fibrillation.

Brief summary: The objective of this study is to compare two different ablation strategies in participants with persistent atrial fibrillation and fibrotic areas in the left atrium. The participant will be randomized to pulmonary vein isolation or pulmonary vein isolation plus ablation of fibrotic areas.

catheter ablation
atrial fibrillation
antiarrhythmic drug
radiofrequency ablation
pulmonary vein isolation
  • 0 views
  • 16 Feb, 2024
  • 1 location
Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial

The purpose for this study is to determine whether left posterior wall isolation (PWI) in addition to pulmonary vein isolation (PVI) is effective as ablation strategy for persistent atrial fibrillation (AF).

catheter ablation
conversion to sinus rhythm
atrial fibrillation
antiarrhythmic drug
pulmonary vein isolation
  • 0 views
  • 16 Feb, 2024
  • 1 location
Acute Atrial Fibrillation and Flutter Treated Electively

The AFFELECT -study compares two types of treatment modalities for acute atrial fibrillation or flutter for patients in whom rhythm control is desirable. The main purpose is to observe if these arrhythmias can be safely treated electively (within 5-9 days).

flecainide
antiarrhythmic drug
thromboembolism
fibrillation
atrial flutter
  • 0 views
  • 16 Feb, 2024
  • 4 locations
Ablation Versus Medical Management of Atrial Fibrillation in HFpEF

This is a prospective non-blinded randomized control pilot study comparing the effect of pulmonary vein isolation against medical management of atrial fibrillation in patients with Heart Failure with preserved Ejection Fraction (HFpEF).

left ventricular end-diastolic pressure
left ventricular hypertrophy
paroxysmal atrial fibrillation
hypertrophy
fibrillation
  • 0 views
  • 16 Feb, 2024
  • 1 location
Cryoballoon Pulmonary Vein Isolation for Atrial Fibrillation With Heart Failure

The combination of atrial fibrillation (AF) and heart failure (HF) is common and implies a poor prognosis. Pulmonary vein isolation is an established method for the treatment of symptomatic AF in patients with normal heart function and has been shown to be more effective than drug therapy.

atrial fibrillation
radiofrequency ablation
pulmonary vein isolation
persistent atrial fibrillation
fibrillation
  • 0 views
  • 16 Feb, 2024
  • 1 location
2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter-based Ablation

The Apple Watch's AF algorithm is based on sampling of heart rate and variability and will give an audible alarm if those parameters indicate a possible episode of AF.

fibrillation
  • 0 views
  • 05 Aug, 2020
Left Bundle Branch Area Pacing (LBBAP) PMCF Study (LBBAP PMCF)

The objective of this study is to evaluate the safety and effectiveness of LBBA pacing/sensing in patients implanted with the Tendril STS 2088TC or UltiPace LPA1231 lead through 6 months post-implant.

  • 0 views
  • 29 Oct, 2025
Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI

Rationale: Transcatheter aortic valve implantation (TAVI) has become the standard therapy for elderly patients with high surgical risks. Paravalvular leakage after TAVI is relatively common and there is conflicting evidence regarding the clinical impact of mild paravalvular leakage in self-expanding devices. Prospective data for self-expanding devices are required to compare …

syncope
stenosis
transcatheter aortic valve implantation
renal failure
symptomatic aortic stenosis
  • 0 views
  • 16 Feb, 2024
  • 1 location
SeQuent Please Neo Multicenter Registry

The registry evaluates the safety and efficacy of paclitaxel-releasing SeQuent Please Neo balloon in the following scenarios: restenosis, bifurcation lesions, small vessel lesions, diabetes (diffuse disease) and atrial fibrillation. The objective is to determine the success of the procedure and the preservation of vascular permeability.

  • 0 views
  • 16 Feb, 2024
  • 1 location